Lebrikizumab shows up to 4 years of sustained control in moderate-to-severe atopic dermatitis
Lebrikizumab provides up to four years of sustained disease control in moderate-to-severe atopic dermatitis Lebrikizumab Almirall, a global biopharmaceutical company dedicated to advancing medical dermatology, has announced encouraging long-term interim results from its ongoing Phase 3b ADlong clinical trial evaluating…
Feinstein Institutes Study Links Brain Structure to Youth Impulsivity
Mapping the Developing Mind: How Brain Structure Predicts Impulsivity in Youth What if subtle differences in the physical structure of the brain could reveal why some young people are more impulsive than others? Could these biological clues help identify early…
Franklin Covey Offers Tailored Solutions to Improve Nurse Retention and Patient Satisfaction
FranklinCovey Empowers Healthcare Organizations with Tailored Solutions to Improve Nurse Retention and Patient Satisfaction A global leader in leadership development and organizational performance, is helping healthcare organizations tackle some of their most urgent challenges through customized, results-driven solutions. As hospitals…
Aledade Partners Outperform Health Systems in Hypertension Control Study
Aledade Partners Drive Superior Hypertension Outcomes Through Innovation and Preventive Care The challenge of managing hypertension continues to loom large over modern healthcare systems, particularly in the United States, where heart disease remains the leading cause of death. Nearly half…
GE HealthCare to Lead EU-Funded Cardio-Oncology Initiative
GE HealthCare to Lead Major EU IHI Consortium Advancing Cardio-Oncology Care The global healthcare landscape is undergoing a profound transformation, driven by rapid technological advancements and an increasing focus on personalized, preventive care. One of the most critical intersections in…
GetHealthy Launches Script, Expanding Practitioner Commerce Beyond Supplements
GetHealthy Launches Script, an AI-Powered Platform Expanding Practitioner Commerce Across Seven Product Categories Beyond Supplements GetHealthy, a company focused on enabling practitioner-driven health commerce, has introduced a new platform called GetHealthy Script—an AI-enabled clinical scripting solution designed to transform how…
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update
Alpha Cognition Reports Strong Fiscal 2025 Results, Highlights Growing Momentum for ZUNVEYL and Strategic Progress Toward Profitability Alpha Cognition ,a biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases, has reported its financial results for the fourth quarter and…
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
Projects $170 Million EBITDA Improvement and Path to Profitability in 2026 P3 Health Partners a physician-led and patient-centered population health management organization, has released its financial results for the fourth quarter and full year ending December 31, 2025, while also…
Pediatrix Strengthens Tennessee Maternal Health Services with Key Partnership
Pediatrix Partners with Tennessee Maternal-Fetal Medicine to Expand Maternal Care Services Pediatrix Medical Group, Inc., a prominent provider of physician services across the United States, has announced a strategic expansion of its maternal health services in Middle Tennessee through a…
GE HealthCare to Lead Major EU-Funded IHI Consortium Advancing Cardio-Oncology Care in Europe
Driving AI-powered early detection, risk prediction, and integrated care pathways to improve cardiovascular outcomes for cancer patients and survivors across Europe. The newly launched COMPASS consortium represents one of the most ambitious and strategically important public-private collaborations under the European…
Agenus to Host March 2026 Webcast on Advancing BOT + BAL Immunotherapy Across Tumors
Agenus to Host March 2026 Webcast on Advancing BOT+BAL Immunotherapy and Expanding Patient Access Agenus , a biotechnology company at the forefront of immuno-oncology innovation, has announced that it will host its March 2026 Stakeholder Webcast, continuing its efforts to…
Rubedo Reports Positive Phase I Results for RLS-1496 in Skin Conditions
Rubedo Life Sciences Reports Encouraging Phase I Results for RLS-1496 in Plaque Psoriasis, Atopic Dermatitis, and Aging Skin Rubedo Life Sciences, a clinical-stage biotechnology company focused on developing innovative therapies targeting cellular aging, has reported encouraging preliminary findings from its…